Effect of chronic antiepileptic treatment on biochemical parameters

C. Erminio, L. Ferini-Strambi, G. Calori, M. Zamboni, S. Iannaccone, S. Smirne

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The influence of chronic antiepileptic treatment on total and conjugated bilirubin, lipid profile, and calcium and magnesium plasma levels was investigated in 294 adult epileptic outpatients undergoing different antiepileptic therapies. A comparison was made with an age- and sex-matched control group. All the antiepileptic groups, excluding the sodium valproate group, showed a significant reduction in total and conjugated bilirubin and a significant increase in total cholesterol and low-density lipoprotein (LDL) cholesterol levels in comparison to the controls. The high-density lipoprotein (HDL) level in the valproic acid group was significantly lower than that in the controls, although no difference was found between the therapeutic groups and the controls for triglycerides, calcium, and magnesium. Our findings indicate that before beginning any antiepileptic treatment, the lipid profile should always be taken into consideration and should be regularly checked throughout the treatment.

Original languageEnglish
Pages (from-to)199-203
Number of pages5
JournalClinical Neuropharmacology
Volume17
Issue number2
Publication statusPublished - 1994

Fingerprint

Anticonvulsants
Valproic Acid
Bilirubin
Magnesium
Calcium
Lipids
Therapeutics
Control Groups
HDL Lipoproteins
LDL Cholesterol
Triglycerides
Research Design
Outpatients
Cholesterol

Keywords

  • Anticonvulsants
  • Bilirubin
  • Calcium
  • Lipid profile
  • Magnesium

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Effect of chronic antiepileptic treatment on biochemical parameters. / Erminio, C.; Ferini-Strambi, L.; Calori, G.; Zamboni, M.; Iannaccone, S.; Smirne, S.

In: Clinical Neuropharmacology, Vol. 17, No. 2, 1994, p. 199-203.

Research output: Contribution to journalArticle

@article{0e792c1af0654fbca442672bbee3cf60,
title = "Effect of chronic antiepileptic treatment on biochemical parameters",
abstract = "The influence of chronic antiepileptic treatment on total and conjugated bilirubin, lipid profile, and calcium and magnesium plasma levels was investigated in 294 adult epileptic outpatients undergoing different antiepileptic therapies. A comparison was made with an age- and sex-matched control group. All the antiepileptic groups, excluding the sodium valproate group, showed a significant reduction in total and conjugated bilirubin and a significant increase in total cholesterol and low-density lipoprotein (LDL) cholesterol levels in comparison to the controls. The high-density lipoprotein (HDL) level in the valproic acid group was significantly lower than that in the controls, although no difference was found between the therapeutic groups and the controls for triglycerides, calcium, and magnesium. Our findings indicate that before beginning any antiepileptic treatment, the lipid profile should always be taken into consideration and should be regularly checked throughout the treatment.",
keywords = "Anticonvulsants, Bilirubin, Calcium, Lipid profile, Magnesium",
author = "C. Erminio and L. Ferini-Strambi and G. Calori and M. Zamboni and S. Iannaccone and S. Smirne",
year = "1994",
language = "English",
volume = "17",
pages = "199--203",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Effect of chronic antiepileptic treatment on biochemical parameters

AU - Erminio, C.

AU - Ferini-Strambi, L.

AU - Calori, G.

AU - Zamboni, M.

AU - Iannaccone, S.

AU - Smirne, S.

PY - 1994

Y1 - 1994

N2 - The influence of chronic antiepileptic treatment on total and conjugated bilirubin, lipid profile, and calcium and magnesium plasma levels was investigated in 294 adult epileptic outpatients undergoing different antiepileptic therapies. A comparison was made with an age- and sex-matched control group. All the antiepileptic groups, excluding the sodium valproate group, showed a significant reduction in total and conjugated bilirubin and a significant increase in total cholesterol and low-density lipoprotein (LDL) cholesterol levels in comparison to the controls. The high-density lipoprotein (HDL) level in the valproic acid group was significantly lower than that in the controls, although no difference was found between the therapeutic groups and the controls for triglycerides, calcium, and magnesium. Our findings indicate that before beginning any antiepileptic treatment, the lipid profile should always be taken into consideration and should be regularly checked throughout the treatment.

AB - The influence of chronic antiepileptic treatment on total and conjugated bilirubin, lipid profile, and calcium and magnesium plasma levels was investigated in 294 adult epileptic outpatients undergoing different antiepileptic therapies. A comparison was made with an age- and sex-matched control group. All the antiepileptic groups, excluding the sodium valproate group, showed a significant reduction in total and conjugated bilirubin and a significant increase in total cholesterol and low-density lipoprotein (LDL) cholesterol levels in comparison to the controls. The high-density lipoprotein (HDL) level in the valproic acid group was significantly lower than that in the controls, although no difference was found between the therapeutic groups and the controls for triglycerides, calcium, and magnesium. Our findings indicate that before beginning any antiepileptic treatment, the lipid profile should always be taken into consideration and should be regularly checked throughout the treatment.

KW - Anticonvulsants

KW - Bilirubin

KW - Calcium

KW - Lipid profile

KW - Magnesium

UR - http://www.scopus.com/inward/record.url?scp=0028258964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028258964&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 199

EP - 203

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 2

ER -